Neuroendocrine cancer foundation. Spitalul Sf. Constantin: Dr. Eugeniu Banu
Conținutul
Chirurgia volumeissue 2, P DOI: Un pacient în vârstă de 57 de ani s-a neuroendocrine cancer foundation cu neuroendocrine cancer foundation neuroendocrine cancer foundation neuroendocrin mixt metastatic MANEC cecal neuroendocrine cancer foundation determinări secundare hepatice şi carcinomatoză peritoneală. S-au efectuat hemicolectomie dreaptă şi omentectomie de urgenţă, urmate de mai multe cicluri de chimioterapie paliativă cu rezultate slabe.
Progresia metastatică a continuat, iar pacientul a decedat la 10 luni de la prezentarea la Camera de Gardă. Localizarea tumorii, precum şi proporţiile şi comportamentul celor două componente ale sale influenţează tratamentul. Totuşi, ghidurile de chimioterapie rămân slab definite, iar prognosticul rămâne unul sumbru, cu supravieţuirea medie sub un an de zile.
AbstractThe aim of this paper is to report the clinicopathological data of one case of mixed metastatic adenoneuroendocrine carcinoma MANEC in the caecum; less neuroendocrine cancer foundation ten cases of which have been described in the English literature. A year-old male patient presented with a mixed adenoneuroendocrine carcinoma MANEC of the caecum with liver metastasis and peritoneal carcinomatosis.
An emergency right hemicolectomy and omentectomy were performed, followed by several cycles of unsuccessful palliative chemotherapy. The metastasis developed further, and the patient died 10 months after presenting to the emergency room.
The location of the tumour and neuroendocrine cancer foundation proportions and behaviour of its two components influence the treatment.
However, chemotherapy guidelines remain poorly defined, and prognosis remains sombre, with median survival of less than one year.